References
- Senarathna SM, Sri Ranganathan S, Buckley N, et al. A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri Lanka. BMC Clin Pharmacol. 2012;12:6.
- Mowry JB, Spyker DA, Brooks DE, et al. 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd annual report. Clinical Toxicology. 2015;53:962–1147.
- Sheen CL, Dillon JF, Bateman DN, et al. Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM. 2002;95:609–619.
- Wong A, Graudins A, Kerr F, et al. Paracetamol toxicity: what would be the implications of a change in Australian treatment guidelines? Emerg Med Australas. 2014;26:183–187.
- Daly FF, Fountain JS, Murray L, et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand–explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust. 2008;188:296–301.
- Daly FFS, O’Malley GF, Heard K, et al. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med. 2004;44:393–398.
- Chiew A, Fountain JS, Graudins A, et al. Summary statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2015;203:215–218.
- Wong A, Graudins A. Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clin Toxicol. 2016;54:115–119.
- Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1252–1254.
- Craig DGN, Bates CM, Davidson JS, et al. Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. Br J Clin Pharmacol. 2011;71:273–282.
- Wong A, Graudins A. Risk prediction of hepatotoxicity in paracetamol poisoning. Clin Toxicol. 2017. DOI:10.1080/15563650.2017.1317349
- Alhelail MA, Hoppe JA, Rhyee SH, et al. Clinical course of repeated supratherapeutic ingestion of acetaminophen. Biol Pharm Bull. 2011;34:349–353.
- MHRA. Benefit risk profile of acetylcysteine in the management of paracetamol overdose [Internet]. 2012 [cited 2017 Mar 31]. Available from: http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con184709.pdf
- Wong A, Landersdorfer C, Graudins A. Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning. Eur J Clin Pharmacol. 2017. DOI:10.1007/s00228-017-2277-4